Dransfield MT - Search Results

1

Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial.

Woodruff PG, Chatila W, Connett JE, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Marchetti N, Rogers TJ, Scanlon PD, Sin DD, Voelker H, Wendt C, Albert RK; COPD Clinical Research Network. Woodruff PG, et al. Among authors: dransfield mt. Eur Respir J. 2014 Jan;43(1):295-8. doi: 10.1183/09031936.00140613. Epub 2013 Oct 17. Eur Respir J. 2014. PMID: 24136332 Free PMC article. Clinical Trial. No abstract available.

2

Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease.

Dransfield MT, Bailey WC. Dransfield MT, et al. Expert Opin Pharmacother. 2004 Aug;5(8):1815-26. doi: 10.1517/14656566.5.8.1815. Expert Opin Pharmacother. 2004. PMID: 15264996 Review.

3

Maintenance pharmacotherapy of chronic obstructive pulmonary disease: an evidence-based approach.

Dransfield MT, Bailey WC. Dransfield MT, et al. Expert Opin Pharmacother. 2005 Jan;6(1):13-25. doi: 10.1517/14656566.6.1.13. Expert Opin Pharmacother. 2005. PMID: 15709879 Review.

4

Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease.

Dransfield MT, Davis JJ, Gerald LB, Bailey WC. Dransfield MT, et al. Respir Med. 2006 Jun;100(6):1110-6. doi: 10.1016/j.rmed.2005.09.019. Epub 2005 Oct 19. Respir Med. 2006. PMID: 16236491 Free article.

5

COPD: racial disparities in susceptibility, treatment, and outcomes.

Dransfield MT, Bailey WC. Dransfield MT, et al. Clin Chest Med. 2006 Sep;27(3):463-71, vii. doi: 10.1016/j.ccm.2006.04.005. Clin Chest Med. 2006. PMID: 16880056 Review.

6

Gender differences in the severity of CT emphysema in COPD.

Dransfield MT, Washko GR, Foreman MG, Estepar RS, Reilly J, Bailey WC. Dransfield MT, et al. Chest. 2007 Aug;132(2):464-70. doi: 10.1378/chest.07-0863. Epub 2007 Jun 15. Chest. 2007. PMID: 17573503

7

Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.

Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB. Dransfield MT, et al. Thorax. 2008 Apr;63(4):301-5. doi: 10.1136/thx.2007.081893. Epub 2007 Oct 19. Thorax. 2008. PMID: 17951276

8

Studying COPD in African-Americans: better late than never.

Dransfield MT, Bailey WC. Dransfield MT, et al. COPD. 2008 Feb;5(1):1-3. doi: 10.1080/15412550701829339. COPD. 2008. PMID: 18259969 No abstract available.

9

Methodology for using long-term accelerometry monitoring to describe daily activity patterns in COPD.

Hecht A, Ma S, Porszasz J, Casaburi R; COPD Clinical Research Network. Hecht A, et al. COPD. 2009 Apr;6(2):121-9. doi: 10.1080/15412550902755044. COPD. 2009. PMID: 19378225 Free PMC article. Clinical Trial.

10

Airway wall attenuation: a biomarker of airway disease in subjects with COPD.

Washko GR, Dransfield MT, Estépar RS, Diaz A, Matsuoka S, Yamashiro T, Hatabu H, Silverman EK, Bailey WC, Reilly JJ. Washko GR, et al. Among authors: dransfield mt. J Appl Physiol (1985). 2009 Jul;107(1):185-91. doi: 10.1152/japplphysiol.00216.2009. Epub 2009 Apr 30. J Appl Physiol (1985). 2009. PMID: 19407254 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

411 results

Search Page